» Articles » PMID: 29985475

Multidimensional Communication in the Microenvirons of Glioblastoma

Overview
Journal Nat Rev Neurol
Specialty Neurology
Date 2018 Jul 10
PMID 29985475
Citations 293
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastomas are heterogeneous and invariably lethal tumours. They are characterized by genetic and epigenetic variations among tumour cells, which makes the development of therapies that eradicate all tumour cells challenging and currently impossible. An important component of glioblastoma growth is communication with and manipulation of other cells in the brain environs, which supports tumour progression and resistance to therapy. Glioblastoma cells recruit innate immune cells and change their phenotype to support tumour growth. Tumour cells also suppress adaptive immune responses, and our increasing understanding of how T cells access the brain and how the tumour thwarts the immune response offers new strategies for mobilizing an antitumour response. Tumours also subvert normal brain cells - including endothelial cells, neurons and astrocytes - to create a microenviron that favours tumour success. Overall, after glioblastoma-induced phenotypic modifications, normal cells cooperate with tumour cells to promote tumour proliferation, invasion of the brain, immune suppression and angiogenesis. This glioblastoma takeover of the brain involves multiple modes of communication, including soluble factors such as chemokines and cytokines, direct cell-cell contact, extracellular vesicles (including exosomes and microvesicles) and connecting nanotubes and microtubes. Understanding these multidimensional communications between the tumour and the cells in its environs could open new avenues for therapy.

Citing Articles

Unlocking the therapeutic potential of tumor-derived EVs in ischemia-reperfusion: a breakthrough perspective from glioma and stroke.

Hao Z, Guan W, Wei W, Li M, Xiao Z, Sun Q J Neuroinflammation. 2025; 22(1):84.

PMID: 40089793 DOI: 10.1186/s12974-025-03405-7.


Exosomal miR-203 from bone marrow stem cells targets the SOCS3/NF-κB pathway to regulate neuroinflammation in temporal lobe epilepsy.

Wang W, Yin J World J Stem Cells. 2025; 17(2):101395.

PMID: 40061262 PMC: 11885937. DOI: 10.4252/wjsc.v17.i2.101395.


Deciphering novel mitochondrial signatures: multi-omics analysis uncovers cross-disease markers and oligodendrocyte pathways in Alzheimer's disease and glioblastoma.

Xu X, Wang J, Chen T, Wang S, Wang F, He J Front Aging Neurosci. 2025; 17:1536142.

PMID: 40018519 PMC: 11865232. DOI: 10.3389/fnagi.2025.1536142.


Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood-Brain Barrier and Actively Targeting Glioma Lesions.

Liu Y, Wu H, Liang G Biomater Res. 2025; 29:0133.

PMID: 39911305 PMC: 11794768. DOI: 10.34133/bmr.0133.


Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment.

Wang L, Gu M, Zhang X, Kong T, Liao J, Zhang D Adv Sci (Weinh). 2025; 12(10):e2413367.

PMID: 39854126 PMC: 11905078. DOI: 10.1002/advs.202413367.


References
1.
Jahani-Asl A, Yin H, Soleimani V, Haque T, Luchman H, Chang N . Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci. 2016; 19(6):798-806. PMC: 4984527. DOI: 10.1038/nn.4295. View

2.
Mei X, Chen Y, Chen F, Xi S, Chen Z . Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging. Neuro Oncol. 2017; 19(8):1109-1118. PMC: 5570159. DOI: 10.1093/neuonc/nox016. View

3.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

4.
Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, Sielska M, Frankowska M, Kaminska B . Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One. 2011; 6(8):e23902. PMC: 3162015. DOI: 10.1371/journal.pone.0023902. View

5.
Okolie O, Bago J, Schmid R, Irvin D, Bash R, Miller C . Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model. Neuro Oncol. 2016; 18(12):1622-1633. PMC: 5791515. DOI: 10.1093/neuonc/now117. View